{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,22]],"date-time":"2026-10-22T15:12:59Z","timestamp":1792681979810,"version":"4.5.0"},"reference-count":60,"publisher":"Springer Science and Business Media LLC","issue":"11","license":[{"start":{"date-parts":[[2018,6,14]],"date-time":"2018-06-14T00:00:00Z","timestamp":1528934400000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"funder":[{"DOI":"10.13039\/501100000024","name":"Canadian Institutes of Health Research","doi-asserted-by":"publisher","award":["258229"],"award-info":[{"award-number":["258229"]}],"id":[{"id":"10.13039\/501100000024","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100008468","name":"Canadian Urological Association","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100008468","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100000156","name":"Fonds de Recherche du Qu\u00e9bec - Sant\u00e9","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100000156","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100013798","name":"Bladder Cancer Canada","doi-asserted-by":"crossref","id":[{"id":"10.13039\/100013798","id-type":"DOI","asserted-by":"crossref"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["World J Urol"],"published-print":{"date-parts":[[2018,11]]},"DOI":"10.1007\/s00345-018-2369-5","type":"journal-article","created":{"date-parts":[[2018,6,14]],"date-time":"2018-06-14T04:07:12Z","timestamp":1528949232000},"page":"1759-1766","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":21,"title":["Modeling human bladder cancer"],"prefix":"10.1007","volume":"36","author":[{"given":"Cassandra","family":"Ringuette-Goulet","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"St\u00e9phane","family":"Bolduc","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Fr\u00e9d\u00e9ric","family":"Pouliot","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2018,6,14]]},"reference":[{"key":"2369_CR1","doi-asserted-by":"publisher","first-page":"7","DOI":"10.3322\/caac.21332","volume":"66","author":"RL Siegel","year":"2016","unstructured":"Siegel RL, Miller KD, Jemal A (2016) Cancer statistics, 2016. CA Cancer J Clin 66:7\u201330. https:\/\/doi.org\/10.3322\/caac.21332","journal-title":"CA Cancer J Clin"},{"key":"2369_CR2","doi-asserted-by":"publisher","first-page":"556","DOI":"10.1016\/j.eursup.2009.06.010","volume":"8","author":"AG Heijden van der","year":"2009","unstructured":"van der Heijden AG, Witjes JA (2009) Recurrence, progression, and follow-up in non-muscle-invasive bladder cancer. Eur Urol Suppl 8:556\u2013562. https:\/\/doi.org\/10.1016\/j.eursup.2009.06.010","journal-title":"Eur Urol Suppl"},{"key":"2369_CR3","doi-asserted-by":"publisher","first-page":"790","DOI":"10.1016\/j.eururo.2006.01.017","volume":"49","author":"JA Witjes","year":"2006","unstructured":"Witjes JA (2006) Management of BCG failures in superficial bladder cancer: a review. Eur Urol 49:790\u2013797. https:\/\/doi.org\/10.1016\/j.eururo.2006.01.017","journal-title":"Eur Urol"},{"key":"2369_CR4","doi-asserted-by":"publisher","first-page":"374","DOI":"10.1093\/carcin\/bgi266","volume":"27","author":"RA Crallan","year":"2006","unstructured":"Crallan RA, Georgopoulos NT, Southgate J (2006) Experimental models of human bladder carcinogenesis. Carcinogenesis 27:374\u2013381. https:\/\/doi.org\/10.1093\/carcin\/bgi266","journal-title":"Carcinogenesis"},{"key":"2369_CR5","first-page":"280","volume":"66","author":"H Druckey","year":"1964","unstructured":"Druckey H (1964) Selective induction of bladder cancer in rats by dibutyl- and N-butyl-N-butanol(4)- nitrosamine. ZeitschriftKrebsforschung 66:280\u2013290","journal-title":"ZeitschriftKrebsforschung"},{"key":"2369_CR6","first-page":"727","volume":"26","author":"C Vasconcelos-N\u00f3brega","year":"2012","unstructured":"Vasconcelos-N\u00f3brega C, Cola\u00e7o A, Lopes C, Oliveira PA (2012) BBN as an urothelial carcinogen. In Vivo 26:727\u2013740","journal-title":"In Vivo"},{"key":"2369_CR7","doi-asserted-by":"publisher","first-page":"373","DOI":"10.3892\/ol_00000066","volume":"1","author":"C Palmeira","year":"2010","unstructured":"Palmeira C, Oliveira PA, Lameiras C et al (2010) Biological similarities between murine chemical-induced and natural human bladder carcinogenesis. Oncol Lett 1:373\u2013377. https:\/\/doi.org\/10.3892\/ol_00000066","journal-title":"Oncol Lett"},{"key":"2369_CR8","doi-asserted-by":"publisher","first-page":"1","DOI":"10.3892\/etm.2014.1837","volume":"8","author":"J Ding","year":"2014","unstructured":"Ding J, Xu D, Pan C et al (2014) Current animal models of bladder cancer: awareness of translatability (review). Exp Ther Med 8:1\u20139. https:\/\/doi.org\/10.3892\/etm.2014.1837","journal-title":"Exp Ther Med"},{"key":"2369_CR9","doi-asserted-by":"publisher","first-page":"e0134346","DOI":"10.1371\/journal.pone.0134346","volume":"10","author":"C-X Pan","year":"2015","unstructured":"Pan C-X, Zhang H, Tepper CG et al (2015) Development and characterization of bladder cancer patient-derived xenografts for molecularly guided targeted therapy. PLoS ONE 10:e0134346. https:\/\/doi.org\/10.1371\/journal.pone.0134346","journal-title":"PLoS ONE"},{"key":"2369_CR10","doi-asserted-by":"publisher","first-page":"2926","DOI":"10.1016\/j.juro.2009.08.020","volume":"182","author":"ESY Chan","year":"2009","unstructured":"Chan ESY, Patel AR, Smith AK et al (2009) Optimizing orthotopic bladder tumor implantation in a syngeneic mouse model. J Urol 182:2926\u20132931. https:\/\/doi.org\/10.1016\/j.juro.2009.08.020","journal-title":"J Urol"},{"key":"2369_CR11","doi-asserted-by":"publisher","first-page":"1799","DOI":"10.1111\/j.1464-410X.2010.09424.x","volume":"106","author":"PC Black","year":"2010","unstructured":"Black PC, Shetty A, Brown GA et al (2010) Validating bladder cancer xenograft bioluminescence with magnetic resonance imaging: the significance of hypoxia and necrosis. BJU Int 106:1799\u20131804. https:\/\/doi.org\/10.1111\/j.1464-410X.2010.09424.x","journal-title":"BJU Int"},{"key":"2369_CR12","doi-asserted-by":"publisher","first-page":"525","DOI":"10.1007\/s00280-014-2376-1","volume":"73","author":"P Cirone","year":"2014","unstructured":"Cirone P, Andresen CJ, Eswaraka JR et al (2014) Patient-derived xenografts reveal limits to PI3K\/mTOR- and MEK-mediated inhibition of bladder cancer. Cancer Chemother Pharmacol 73:525\u2013538. https:\/\/doi.org\/10.1007\/s00280-014-2376-1","journal-title":"Cancer Chemother Pharmacol"},{"key":"2369_CR13","first-page":"4227","volume":"9","author":"T Voskoglou-Nomikos","year":"2003","unstructured":"Voskoglou-Nomikos T, Pater JL, Seymour L (2003) Clinical predictive value of the in vitro cell line. Human Xenograft Mouse Allograft Preclin Cancer Models 9:4227\u20134239","journal-title":"Human Xenograft Mouse Allograft Preclin Cancer Models"},{"key":"2369_CR14","doi-asserted-by":"publisher","first-page":"e1265720","DOI":"10.1080\/2162402X.2016.1265720","volume":"6","author":"S Domingos-Pereira","year":"2016","unstructured":"Domingos-Pereira S, Cesson V, Chevalier MF et al (2016) Preclinical efficacy and safety of the Ty21a vaccine strain for intravesical immunotherapy of non-muscle-invasive bladder cancer. OncoImmunology 6:e1265720\u2013e1265727. https:\/\/doi.org\/10.1080\/2162402X.2016.1265720","journal-title":"OncoImmunology"},{"key":"2369_CR15","doi-asserted-by":"publisher","first-page":"805","DOI":"10.1016\/S0002-9440(10)64594-4","volume":"157","author":"PJ Grippo","year":"2000","unstructured":"Grippo PJ, Sandgren EP (2000) Highly invasive transitional cell carcinoma of the bladder in a simian virus 40 T-antigen transgenic mouse model. Am J Pathol 157:805\u2013813. https:\/\/doi.org\/10.1016\/S0002-9440(10)64594-4","journal-title":"Am J Pathol"},{"key":"2369_CR16","doi-asserted-by":"publisher","first-page":"e13821","DOI":"10.1371\/journal.pone.0013821","volume":"5","author":"LC Kompier","year":"2010","unstructured":"Kompier LC, Lurkin I, van der Aa MNM et al (2010) FGFR3, HRAS, KRAS, NRAS and PIK3CA mutations in bladder cancer and their potential as biomarkers for surveillance and therapy. PLoS ONE 5:e13821. https:\/\/doi.org\/10.1371\/journal.pone.0013821","journal-title":"PLoS ONE"},{"key":"2369_CR17","doi-asserted-by":"publisher","first-page":"1973","DOI":"10.1038\/sj.onc.1204315","volume":"20","author":"Z-T Zhang","year":"2001","unstructured":"Zhang Z-T, Pak J, Wu X-R et al (2001) Role of Ha-ras activation in superficial papillary pathway of urothelial tumor formation. Oncogene 20:1973\u20131980","journal-title":"Oncogene"},{"key":"2369_CR18","first-page":"3512","volume":"59","author":"Z-T Zhang","year":"1999","unstructured":"Zhang Z-T, Pak J, Shapiro E et al (1999) Urothelium-specific expression of an oncogene in transgenic mice induced the formation of carcinoma. Can Res 59:3512\u20133517","journal-title":"Can Res"},{"key":"2369_CR19","first-page":"4157","volume":"62","author":"J Cheng","year":"2002","unstructured":"Cheng J, Huang H, Zhang Z-T et al (2002) Overexpression of epidermal growth factor receptor in urothelium elicits urothelial hyperplasia and promotes bladder tumor growth. Can Res 62:4157\u20134163","journal-title":"Can Res"},{"key":"2369_CR20","doi-asserted-by":"publisher","first-page":"548","DOI":"10.1242\/dmm.006874","volume":"4","author":"I Ahmad","year":"2011","unstructured":"Ahmad I, Singh LB, Foth M et al (2011) K-Ras and B-catenin mutations cooperate with Fgfr3 mutations in mice to promote tumorigenesis in the skin and lung, but not in the bladder. Dis Models Mech 4:548\u2013555. https:\/\/doi.org\/10.1242\/dmm.006874","journal-title":"Dis Models Mech"},{"key":"2369_CR21","doi-asserted-by":"publisher","first-page":"F387","DOI":"10.1152\/ajprenal.00185.2010","volume":"299","author":"H Zhou","year":"2010","unstructured":"Zhou H, Liu Y, He F et al (2010) Temporally and spatially controllable gene expression and knockout in mouse urothelium. Am J Physiol Renal Physiol 299:F387\u2013F395. https:\/\/doi.org\/10.1152\/ajprenal.00185.2010","journal-title":"Am J Physiol Renal Physiol"},{"key":"2369_CR22","doi-asserted-by":"publisher","first-page":"20778","DOI":"10.1074\/jbc.M110.198069","volume":"286","author":"FA la Pena de","year":"2011","unstructured":"la Pena de FA, Kanasaki K, Kanasaki M et al (2011) Loss of p53 and acquisition of angiogenic MicroRNA profile are insufficient to facilitate progression of bladder urothelial carcinoma in situ to invasive carcinoma. J Biol Chem 286:20778\u201320787","journal-title":"J Biol Chem"},{"key":"2369_CR23","doi-asserted-by":"publisher","DOI":"10.1016\/j.eururo.2016.06.010","author":"S Antoni","year":"2016","unstructured":"Antoni S, Ferlay J, Soerjomataram I et al (2016) Bladder cancer incidence and mortality: a global overview and recent trends. Eur Urol. https:\/\/doi.org\/10.1016\/j.eururo.2016.06.010","journal-title":"Eur Urol"},{"key":"2369_CR24","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1038\/nrdp.2017.22","volume":"3","author":"O Sanli","year":"2017","unstructured":"Sanli O, Dobruch J, Knowles MA et al (2017) Bladder cancer. Nat Publ Group 3:1\u201319. https:\/\/doi.org\/10.1038\/nrdp.2017.22","journal-title":"Nat Publ Group"},{"key":"2369_CR25","doi-asserted-by":"crossref","first-page":"12261","DOI":"10.18632\/oncotarget.24301","volume":"9","author":"KW Luo","year":"2018","unstructured":"Luo KW, Lung WY, Xie C et al (2018) EGCG inhibited bladder cancer T24 and 5637 cell proliferation and migration via PI3\u00a0K\/AKT pathway. Oncotarget 9:12261\u201312272","journal-title":"Oncotarget"},{"key":"2369_CR26","doi-asserted-by":"publisher","first-page":"3864","DOI":"10.3892\/ol.2018.7727","volume":"15","author":"X Zhang","year":"2018","unstructured":"Zhang X, Chen Y, Dong L, Shi B (2018) Effect of selective inhibition of aquaporin 1 on chemotherapy sensitivity of J82 human bladder cancer cells. Oncol Lett 15:3864\u20133869. https:\/\/doi.org\/10.3892\/ol.2018.7727","journal-title":"Oncol Lett"},{"key":"2369_CR27","doi-asserted-by":"publisher","first-page":"e20584","DOI":"10.1371\/journal.pone.0020584","volume":"6","author":"PT Hennessey","year":"2011","unstructured":"Hennessey PT, Ochs MF, Mydlarz WW et al (2011) Promoter methylation in head and neck squamous cell carcinoma cell lines is significantly different than methylation in primary tumors and xenografts. PLoS One 6:e20584\u2013e20587. https:\/\/doi.org\/10.1371\/journal.pone.0020584","journal-title":"PLoS One"},{"key":"2369_CR28","doi-asserted-by":"publisher","first-page":"189","DOI":"10.1038\/nrclinonc.2011.34","volume":"8","author":"L Hutchinson","year":"2011","unstructured":"Hutchinson L, Kirk R (2011) High drug attrition rates\u2014where are we going wrong? Nat Publ Group 8:189\u2013190. https:\/\/doi.org\/10.1038\/nrclinonc.2011.34","journal-title":"Nat Publ Group"},{"key":"2369_CR29","doi-asserted-by":"publisher","first-page":"177","DOI":"10.1126\/science.2451290","volume":"240","author":"RM Sutherland","year":"1988","unstructured":"Sutherland RM (1988) Cell and environment interactions in tumor microregions: the multicell spheroid model. Science 240:177\u2013184","journal-title":"Science"},{"key":"2369_CR30","doi-asserted-by":"publisher","first-page":"20131124","DOI":"10.1098\/rsif.2013.1124","volume":"11","author":"DR Grimes","year":"2013","unstructured":"Grimes DR, Kelly C, Bloch K, Partridge M (2013) A method for estimating the oxygen consumption rate in multicellular tumour spheroids. J R Soc Interface 11:20131124. https:\/\/doi.org\/10.1098\/rsif.2013.1124","journal-title":"J R Soc Interface"},{"key":"2369_CR31","doi-asserted-by":"publisher","first-page":"870","DOI":"10.3389\/fphys.2017.00605","volume":"8","author":"RLF Amaral","year":"2017","unstructured":"Amaral RLF, Miranda M, Marcato PD, Swiech K (2017) Comparative analysis of 3D bladder tumor spheroids obtained by forced floating and hanging drop methods for drug screening. Front Physiol 8:870\u2013875. https:\/\/doi.org\/10.3389\/fphys.2017.00605","journal-title":"Front Physiol"},{"key":"2369_CR32","doi-asserted-by":"publisher","first-page":"29","DOI":"10.1186\/1741-7007-10-29","volume":"10","author":"M Vinci","year":"2012","unstructured":"Vinci M, Gowan S, Boxall F et al (2012) Advances in establishment and analysis of three-dimensional tumor spheroid-based functional assays for target validation and drug evaluation. BMC Biol 10:29. https:\/\/doi.org\/10.1186\/1741-7007-10-29","journal-title":"BMC Biol"},{"key":"2369_CR33","first-page":"1397","volume":"49","author":"R Knuchel","year":"1989","unstructured":"Knuchel R, Hofst\u00e4dter F, Jenkins WEA, Masters JRW (1989) Sensitivities of monolayers and spheroids of the human bladder cancer cell line mgh-u1 to the drugs used for intravesical chemotherapy. Can Res 49:1397\u20131401","journal-title":"Can Res"},{"key":"2369_CR34","doi-asserted-by":"publisher","first-page":"962","DOI":"10.1016\/j.eururo.2006.10.034","volume":"51","author":"JP Burgu\u00e9s","year":"2007","unstructured":"Burgu\u00e9s JP, G\u00f3mez L, Pontones JL et al (2007) A chemosensitivity test for superficial bladder cancer based on three-dimensional culture of tumour spheroids. Eur Urol 51:962\u2013970. https:\/\/doi.org\/10.1016\/j.eururo.2006.10.034","journal-title":"Eur Urol"},{"key":"2369_CR35","doi-asserted-by":"publisher","first-page":"75","DOI":"10.1016\/j.yexcr.2012.09.012","volume":"319","author":"K Chitcholtan","year":"2013","unstructured":"Chitcholtan K, Asselin \u00c9, Parent S et al (2013) Differences in growth properties of endometrial cancer in three dimensional (3D) culture and 2D cell monolayer. Exp Cell Res 319:75\u201387. https:\/\/doi.org\/10.1016\/j.yexcr.2012.09.012","journal-title":"Exp Cell Res"},{"key":"2369_CR36","doi-asserted-by":"publisher","first-page":"378","DOI":"10.3109\/10428194.2013.793323","volume":"55","author":"OS Aljitawi","year":"2013","unstructured":"Aljitawi OS, Li D, Xiao Y et al (2013) A novel three-dimensional stromal-based model for in vitro chemotherapy sensitivity testing of leukemia cells. Leuk Lymp 55:378\u2013391. https:\/\/doi.org\/10.3109\/10428194.2013.793323","journal-title":"Leuk Lymp"},{"key":"2369_CR37","doi-asserted-by":"publisher","first-page":"e0130348","DOI":"10.1371\/journal.pone.0130348","volume":"10","author":"X Gong","year":"2015","unstructured":"Gong X, Lin C, Cheng J et al (2015) Generation of multicellular tumor spheroids with microwell-based agarose scaffolds for drug testing. PLoS One 10:e0130348. https:\/\/doi.org\/10.1371\/journal.pone.0130348","journal-title":"PLoS One"},{"key":"2369_CR38","doi-asserted-by":"publisher","first-page":"557","DOI":"10.1097\/00001813-200207000-00002","volume":"13","author":"RT Kilani","year":"2002","unstructured":"Kilani RT, Tamimi Y, Karmali S et al (2002) Selective cytotoxicity of gemcitabine in bladder cancer cell lines. Anticancer Drugs 13:557\u2013566","journal-title":"Anticancer Drugs"},{"key":"2369_CR39","doi-asserted-by":"publisher","first-page":"1","DOI":"10.3389\/fcell.2015.00033","volume":"3","author":"R Bhome","year":"2015","unstructured":"Bhome R, Bullock MD, Saihati Al HA et al (2015) A top-down view of the tumor microenvironment: structure, cells and signaling. Front Cell Dev Biol 3:1\u20139. https:\/\/doi.org\/10.3389\/fcell.2015.00033","journal-title":"Front Cell Dev Biol"},{"key":"2369_CR40","doi-asserted-by":"publisher","first-page":"8608","DOI":"10.1016\/j.biomaterials.2010.07.075","volume":"31","author":"L-S Wang","year":"2010","unstructured":"Wang L-S, Boulaire J, Chan PPY et al (2010) The role of stiffness of gelatin-hydroxyphenylpropionic acid hydrogels formed by enzyme-mediated crosslinking on the differentiation of human mesenchymal stem cell. Biomaterials 31:8608\u20138616. https:\/\/doi.org\/10.1016\/j.biomaterials.2010.07.075","journal-title":"Biomaterials"},{"key":"2369_CR41","doi-asserted-by":"publisher","first-page":"4337","DOI":"10.1016\/S0142-9612(03)00340-5","volume":"24","author":"JL Drury","year":"2003","unstructured":"Drury JL, Mooney DJ (2003) Hydrogels for tissue engineering: scaffold design variables and applications. Biomaterials 24:4337\u20134351. https:\/\/doi.org\/10.1016\/S0142-9612(03)00340-5","journal-title":"Biomaterials"},{"key":"2369_CR42","doi-asserted-by":"publisher","first-page":"6188","DOI":"10.1021\/bi00267a025","volume":"21","author":"HK Kleinman","year":"1982","unstructured":"Kleinman HK, McGarvey ML, Liotta LA et al (1982) Isolation and characterization of type IV procollagen, laminin, and heparan sulfate proteoglycan from the EHS sarcoma. Biochemistry 21:6188\u20136193. https:\/\/doi.org\/10.1021\/bi00267a025","journal-title":"Biochemistry"},{"key":"2369_CR43","doi-asserted-by":"publisher","first-page":"10","DOI":"10.1186\/1471-2407-6-12","volume":"6","author":"MG Dozmorov","year":"2006","unstructured":"Dozmorov MG, Kyker KD, Saban R et al (2006) Analysis of the interaction of extracellular matrix and phenotype of bladder cancer cells. BMC Cancer 6:10\u201312. https:\/\/doi.org\/10.1186\/1471-2407-6-12","journal-title":"BMC Cancer"},{"issue":"2","key":"2369_CR44","first-page":"737","volume":"27","author":"PJ Hauser","year":"2007","unstructured":"Hauser PJ, Han Z, Sindhwani P, Hurst RE (2007) Sensitivity of bladder cancer cells to curcumin and its derivatives depends on the extracellular matrix. Anticancer Res 27(2):737\u2013740","journal-title":"Anticancer Res"},{"key":"2369_CR45","doi-asserted-by":"publisher","first-page":"29","DOI":"10.1016\/j.addr.2014.03.001","volume":"69\u201370","author":"CR Thoma","year":"2014","unstructured":"Thoma CR, Zimmermann M, Agarkova I et al (2014) 3D cell culture systems modeling tumor growth determinants in cancer target discovery. Adv Drug Deliv Rev 69\u201370:29\u201341. https:\/\/doi.org\/10.1016\/j.addr.2014.03.001","journal-title":"Adv Drug Deliv Rev"},{"key":"2369_CR46","doi-asserted-by":"publisher","first-page":"109","DOI":"10.1016\/S0248-4900(94)80013-8","volume":"82","author":"H-J Boxberger","year":"1994","unstructured":"Boxberger H-J, Meyer TF (1994) A new method for the 3-D in vitro growth of human RTll2 bladder carcinoma cells using the alginate culture technique. Biol Cell 82:109\u2013119","journal-title":"Biol Cell"},{"key":"2369_CR47","doi-asserted-by":"publisher","first-page":"413","DOI":"10.1016\/j.semcancer.2005.05.007","volume":"15","author":"S Zhang","year":"2005","unstructured":"Zhang S, Gelain F, Zhao X (2005) Designer self-assembling peptide nanofiber scaffolds for 3D tissue cell cultures. Semin Cancer Biol 15:413\u2013420. https:\/\/doi.org\/10.1016\/j.semcancer.2005.05.007","journal-title":"Semin Cancer Biol"},{"key":"2369_CR48","doi-asserted-by":"publisher","first-page":"38","DOI":"10.5339\/gcsp.2013.38","volume":"2013","author":"IM El-Sherbiny","year":"2013","unstructured":"El-Sherbiny IM, Yacoub MH (2013) Hydrogel scaffolds for tissue engineering: progress and challenges. Glob Cardiol Sci Pract 2013:38. https:\/\/doi.org\/10.5339\/gcsp.2013.38","journal-title":"Glob Cardiol Sci Pract"},{"key":"2369_CR49","doi-asserted-by":"publisher","first-page":"1964","DOI":"10.1021\/mp500065m","volume":"11","author":"SC Baker","year":"2014","unstructured":"Baker SC, Shabir S, Southgate J (2014) Biomimetic urothelial tissue models for the in vitro evaluation of barrier physiology and bladder drug efficacy. Mol Pharmaceut 11:1964\u20131970. https:\/\/doi.org\/10.1021\/mp500065m","journal-title":"Mol Pharmaceut"},{"key":"2369_CR50","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1186\/s40478-014-0181-z","volume":"3","author":"B Par\u00e9","year":"2015","unstructured":"Par\u00e9 B, Touzel-Deschenes L, Lamontagne R et al (2015) Early detection of structural abnormalities and cytoplasmic accumulation of TDP-43 in tissue-engineered skins derived from ALS patients. Acta Neuropathol Commun 3:1\u201312. https:\/\/doi.org\/10.1186\/s40478-014-0181-z","journal-title":"Acta Neuropathol Commun"},{"key":"2369_CR51","doi-asserted-by":"publisher","first-page":"83","DOI":"10.1007\/s10585-012-9511-3","volume":"30","author":"L Gibot","year":"2012","unstructured":"Gibot L, Galbraith T, Huot J, Auger FA (2012) Development of a tridimensional microvascularized human skin substitute to study melanoma biology. Clin Exp Metastasis 30:83\u201390. https:\/\/doi.org\/10.1007\/s10585-012-9511-3","journal-title":"Clin Exp Metastasis"},{"key":"2369_CR52","doi-asserted-by":"publisher","first-page":"7917","DOI":"10.1016\/j.actbio.2013.04.028","volume":"9","author":"A Nyga","year":"2013","unstructured":"Nyga A, Loizidou M, Emberton M, Cheema U (2013) A novel tissue engineered three-dimensional in vitro colorectal cancer model. Acta Biomater 9:7917\u20137926. https:\/\/doi.org\/10.1016\/j.actbio.2013.04.028","journal-title":"Acta Biomater"},{"key":"2369_CR53","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1089\/107632701300003241","volume":"7","author":"M Yamato","year":"2001","unstructured":"Yamato M, Utsumi M, Kushida A et al (2001) Thermo-responsive culture dishes allow the intact harvest of multilayered keratinocyte sheets without dispase by reducing temperature. Tissue Eng Part A 7:1\u20138","journal-title":"Tissue Eng Part A"},{"key":"2369_CR54","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1155\/2016\/5397319","volume":"2016","author":"S Chabaud","year":"2016","unstructured":"Chabaud S, Bolduc SP (2016) Production of a self-aligned scaffold, free of exogenous material, from dermal fibroblasts using the self-assembly technique. Dermatol Res Pract 2016:1\u20139. https:\/\/doi.org\/10.1155\/2016\/5397319","journal-title":"Dermatol Res Pract"},{"key":"2369_CR55","doi-asserted-by":"publisher","first-page":"233","DOI":"10.1016\/j.biomaterials.2017.08.041","volume":"145","author":"C Ringuette-Goulet","year":"2017","unstructured":"Ringuette-Goulet C, Bernard G, Chabaud S et al (2017) Tissue-engineered human 3D model of bladder cancer for invasion study and drug discovery. Biomaterials 145:233\u2013241. https:\/\/doi.org\/10.1016\/j.biomaterials.2017.08.041","journal-title":"Biomaterials"},{"key":"2369_CR56","doi-asserted-by":"publisher","first-page":"119","DOI":"10.1046\/j.1464-410X.2002.02522.x","volume":"89","author":"K Nakamura","year":"2015","unstructured":"Nakamura K, Fujiyama C, Tokuda Y et al (2015) Bladder cancer cell implantation in reconstructed bladder in vitro: a model of tumour recurrence. BJU Int 89:119\u2013125","journal-title":"BJU Int"},{"key":"2369_CR57","doi-asserted-by":"publisher","first-page":"1077","DOI":"10.1038\/nprot.2017.025","volume":"12","author":"L Gibot","year":"2017","unstructured":"Gibot L, Galbraith T, Bourland J et al (2017) Tissue-engineered 3D human lymphatic microvascular network for in vitro studies of lymphangiogenesis. Nat Protoc 12:1077\u20131088. https:\/\/doi.org\/10.1038\/nprot.2017.025","journal-title":"Nat Protoc"},{"key":"2369_CR58","doi-asserted-by":"publisher","first-page":"4099","DOI":"10.7150\/thno.20730","volume":"7","author":"A Villasante","year":"2018","unstructured":"Villasante A, Sakaguchi K, Kim J et al (2018) Vascularized tissue-engineered model for studying drug resistance in neuroblastoma. Theranostics 7:4099\u20134117. https:\/\/doi.org\/10.7150\/thno.20730","journal-title":"Theranostics"},{"key":"2369_CR59","doi-asserted-by":"publisher","DOI":"10.1016\/j.nano.2015.09.010","author":"W Zhu","year":"2015","unstructured":"Zhu W, Holmes B, Glazer RI, Zhang LG (2015) 3D printed nanocomposite matrix for the study of breast cancer bone metastasis. Nanomed Nanotechnol Biol Med. https:\/\/doi.org\/10.1016\/j.nano.2015.09.010","journal-title":"Nanomed Nanotechnol Biol Med"},{"key":"2369_CR60","doi-asserted-by":"publisher","first-page":"e0159013","DOI":"10.1371\/journal.pone.0159013","volume":"11","author":"S-Y Jeong","year":"2016","unstructured":"Jeong S-Y, Lee J-H, Shin Y et al (2016) Co-culture of tumor spheroids and fibroblasts in a collagen matrix-incorporated microfluidic chip mimics reciprocal activation in solid tumor microenvironment. PLoS One 11:e0159013\u2013e0159017. https:\/\/doi.org\/10.1371\/journal.pone.0159013","journal-title":"PLoS One"}],"container-title":["World Journal of Urology"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s00345-018-2369-5\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s00345-018-2369-5.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s00345-018-2369-5.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2020,11,3]],"date-time":"2020-11-03T14:33:13Z","timestamp":1604413993000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s00345-018-2369-5"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2018,6,14]]},"references-count":60,"journal-issue":{"issue":"11","published-print":{"date-parts":[[2018,11]]}},"alternative-id":["2369"],"URL":"https:\/\/doi.org\/10.1007\/s00345-018-2369-5","relation":{},"ISSN":["0724-4983","1433-8726"],"issn-type":[{"value":"0724-4983","type":"print"},{"value":"1433-8726","type":"electronic"}],"subject":[],"published":{"date-parts":[[2018,6,14]]},"assertion":[{"value":"1 February 2018","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"25 May 2018","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"14 June 2018","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Compliance with ethical standards"}},{"value":"The authors declare that there is no conflict of interest regarding the publication of this paper.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of interest"}}]}}